Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 43, 2011 - Issue 6-7
Submit an article Journal homepage
611
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v

Eskild PetersenDepartment of Infectious DiseasesCorrespondence[email protected]
,
Dorte B. KeldIntensive Care Unit, Department of Anaesthesiology
,
Svend Ellermann-EriksenDepartment of Clinical Microbiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
,
Sophie GubbelsEuropean Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden;Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
,
Susanne IlkjærIntensive Care Unit, Department of Anaesthesiology
,
Søren Jensen-FangelDepartment of Infectious Diseases
&
Christian LindskovIntensive Care Unit, Department of Anaesthesiology
 show all
Pages 495-503 | Received 15 Jul 2010, Accepted 17 Jan 2011, Published online: 10 Feb 2011

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joon Young Song, Ji Yun Noh, Won Suk Choi, Hee Jin Cheong & Woo Joo Kim. (2015) Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives. Expert Review of Anti-infective Therapy 13:11, pages 1361-1372.
Read now

Articles from other publishers (28)

Zehua Jin, Hongda Sheng, Shufang Wang, Yi Wang & Yiyu Cheng. (2022) Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activation. Journal of Ethnopharmacology, pages 115513.
Crossref
Yaqin Bai, Jeremy C. Jones, Sook-San Wong & Mark Zanin. (2021) Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance. Viruses 13:4, pages 624.
Crossref
Eskild Petersen, Marion Koopmans, Unyeong Go, Davidson H Hamer, Nicola Petrosillo, Francesco Castelli, Merete Storgaard, Sulien Al Khalili & Lone Simonsen. (2020) Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet Infectious Diseases 20:9, pages e238-e244.
Crossref
Temi Lampejo. (2020) Influenza and antiviral resistance: an overview. European Journal of Clinical Microbiology & Infectious Diseases 39:7, pages 1201-1208.
Crossref
Carlo Torti, Maria Mazzitelli, Federico Longhini, Eugenio Garofalo, Andrea Bruni, Aida Giancotti, Giorgio Settimo Barreca, Angela Quirino, Maria Carla Liberto, Francesca Serapide, Giovanni Matera, Enrico Maria Trecarichi & Paolo Navalesi. (2019) Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. BMC Infectious Diseases 19:1.
Crossref
S. Tekin, S. Keske, S. Alan, A. Batirel, C. Karakoc, N. Tasdelen-Fisgin, S. Simsek-Yavuz, B. Işler, M. Aydin, M. Kapmaz, F. Yilmaz-Karadag & O. Ergonul. (2019) Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season. International Journal of Infectious Diseases 81, pages 6-9.
Crossref
Camilly P. Pires de Mello, George L. Drusano, Jonathan R. Adams, Matthew Shudt, Robert Kulawy & Ashley N. Brown. (2018) Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system. European Journal of Pharmaceutical Sciences 111, pages 443-449.
Crossref
Candela Solé-Lleonart, Jean-Jacques Rouby, Stijn Blot, Garyfallia Poulakou, Jean Chastre, Lucy B. Palmer, Matteo Bassetti, Charles-Edouard Luyt, Jose M. Pereira, Jordi Riera, Tim Felton, Jayesh Dhanani, Tobias Welte, Jose M. Garcia-Alamino, Jason A. Roberts & Jordi Rello. (2017) Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults. Anesthesiology 126:5, pages 890-908.
Crossref
Erhard van der Vries & Michael G. Ison. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance 1165 1183 .
Yan Zhang, Hainv Gao, Weifeng Liang, Lingling Tang, Yida Yang, Xiaoxin Wu, Liang Yu, Ping Chen, Shufa Zheng, Huilin Ou & Lanjuan Li. (2016) Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study. BMC Infectious Diseases 16:1.
Crossref
Tony Velkov, Nusaibah Abdul Rahim, Qi (Tony) Zhou, Hak-Kim Chan & Jian Li. (2015) Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead. Advanced Drug Delivery Reviews 85, pages 65-82.
Crossref
Wouter J. Meijer, Wiete Kromdijk, Marcel P. H. van den Broek, Pieter-Jan A. Haas, Monique C. Minnema, Charles A. Boucher, Dylan W. de Lange & Annemarie M. J. Wensing. (2015) Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Case Reports in Infectious Diseases 2015, pages 1-4.
Crossref
Jake Dunning, J Kenneth Baillie, Bin Cao & Frederick G Hayden. (2014) Antiviral combinations for severe influenza. The Lancet Infectious Diseases 14:12, pages 1259-1270.
Crossref
Michael G Ison, Joseph Fraiz, Barry Heller, Luis Jauregui, Graham Mills, William O'Riordan, Brian O'Neil, E Geoffrey Playford, J Douglass Rolf, Eduardo Sada-Diaz, Jenna Elder, Phil Collis, Jaime E Hernandez & William P Sheridan. (2013) Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients. Antiviral Therapy 19:4, pages 349-361.
Crossref
James E. Fielding, Heath A. Kelly, Geoffry N. Mercer & Kathryn Glass. (2014) Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. Influenza and Other Respiratory Viruses 8:2, pages 142-150.
Crossref
Won Suk ChoiJi Hyeon BaekYu Bin SeoSae Yoon KeeHye Won JeongHee Young LeeByung Wook EunEun Ju ChooJacob LeeYoung Keun KimJoon Young SongSeong-Heon WieJin Soo LeeHee Jin CheongWoo Joo Kim. (2014) Severe Influenza Treatment Guideline. Korean Journal of Medicine 86:1, pages 116.
Crossref
Won Suk ChoiJi Hyeon BaekYu Bin SeoSae Yoon KeeHye Won JeongHee Young LeeByung Wook EunEun Ju ChooJacob LeeYoung Keun KimJoon Young SongSeong-Heon WieJin Soo LeeHee Jin CheongWoo Joo Kim. (2014) Severe influenza treatment guideline. The Korean Journal of Internal Medicine 29:1, pages 132.
Crossref
Iben Ørsted, Mette Mølvadgaard, Hans Linde Nielsen & Henrik Nielsen. (2013) The first, second and third wave of pandemic influenza A (H1N1)pdm09 in North Denmark Region 2009-2011: a population-based study of hospitalizations. Influenza and Other Respiratory Viruses 7:5, pages 776-782.
Crossref
Anna Gillman, Shaman Muradrasoli, Hanna S?derstr?m, Johan Nordh, Caroline Br?jer, Richard H. Lindberg, Neus Latorre-Margalef, Jonas Waldenstr?m, Bj?rn Olsen & Josef D. J?rhult. (2013) Resistance Mutation R292K Is Induced in Influenza A(H6N2) Virus by Exposure of Infected Mallards to Low Levels of Oseltamivir. PLoS ONE 8:8, pages e71230.
Crossref
Babak Jalilian, Stig Hill Christiansen, Halldór Bjarki Einarsson, Mehdi Rasoli Pirozyan, Eskild Petersen & Thomas Vorup-Jensen. (2013) Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?. Molecular and Cellular Therapies 1:1, pages 2.
Crossref
Pieter L. A. Fraaij, Erhard van der Vries & Albert D. M. E. Osterhaus. (2013) Reply to Chan-Tack et al. The Journal of Infectious Diseases 207:1, pages 198-199.
Crossref
Erhard van der Vries, Martin Schutten, Pieter Fraaij, Charles Boucher & Albert Osterhaus. 2013. Antiviral Agents. Antiviral Agents 217 246 .
Vanessa Escuret, Catherine Cornu, Florent Boutitie, Vincent Enouf, Anne Mosnier, Maude Bouscambert-Duchamp, S?gol?ne Gaillard, Xavier Duval, Thierry Blanchon, Catherine Leport, Fran?ois Gueyffier, Sylvie Van Der Werf & Bruno Lina. (2012) Oseltamivir?zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. Antiviral Research 96:2, pages 130-137.
Crossref
Janice K. Louie, Samuel Yang, Cynthia Yen, Meileen Acosta, Robert Schechter & Timothy M. Uyeki. (2012) Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09. PLoS ONE 7:6, pages e40261.
Crossref
Aeron C Hurt, Tawee Chotpitayasunondh, Nancy J Cox, Rod Daniels, Alicia M Fry, Larisa V Gubareva, Frederick G Hayden, David S Hui, Olav Hungnes, Angie Lackenby, Wilina Lim, Adam Meijer, Charles Penn, Masato Tashiro, Timothy M Uyeki & Maria Zambon. (2012) Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. The Lancet Infectious Diseases 12:3, pages 240-248.
Crossref
Sehee ParkJin Il KimMan-Seong Park. (2012) Antiviral Agents Against Influenza Viruses. Journal of Bacteriology and Virology 42:4, pages 284.
Crossref
Erhard van der Vries, Martin Schutten & Charles A.B. Boucher. (2011) The potential for multidrug-resistant influenza. Current Opinion in Infectious Diseases 24:6, pages 599-604.
Crossref
Pieter L.A. Fraaij & Terho Heikkinen. (2011) Seasonal influenza: The burden of disease in children. Vaccine 29:43, pages 7524-7528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.